Breaking News

Over a week ago
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
Conference/Events
UBS to hold a virtual conference » 04:55
05/20/20
05/20
04:55
05/20/20
04:55
RDHL

RedHill Biopharma

$7.19 /

+0.28 (+4.05%)

, ANGO

AngioDynamics

$11.05 /

+0.11 (+1.01%)

, CDXS

Codexis

$11.15 /

-0.42 (-3.63%)

, AHCO

AdaptHealth

$16.68 /

+0.18 (+1.09%)

, APLT

Applied Therapeutics

$47.53 /

+2.41 (+5.34%)

, TFX

Teleflex

$346.33 /

-6.665 (-1.89%)

, UHS

Universal Health

$101.01 /

+0.55 (+0.55%)

, HRC

Hill-Rom

$98.94 /

-2.17 (-2.15%)

, NVRO

Nevro

$122.31 /

+0.47 (+0.39%)

, AMED

Amedisys

$190.01 /

-2.98 (-1.54%)

, ESTA

Establishment Labs

$16.25 /

-0.86 (-5.03%)

, HUM

Humana

$395.51 /

+4.41 (+1.13%)

, VKTX

Viking Therapeutics

$7.05 /

-0.09 (-1.26%)

, WST

West Pharmaceutical

$211.46 /

-7.14 (-3.27%)

Global Healthcare Virtual…

Global Healthcare Virtual Conference will be held on May 18-20.

ShowHide Related Items >><<
WST West Pharmaceutical
$211.46 /

-7.14 (-3.27%)

VKTX Viking Therapeutics
$7.05 /

-0.09 (-1.26%)

UHS Universal Health
$101.01 /

+0.55 (+0.55%)

TFX Teleflex
$346.33 /

-6.665 (-1.89%)

RDHL RedHill Biopharma
$7.19 /

+0.28 (+4.05%)

NVRO Nevro
$122.31 /

+0.47 (+0.39%)

HUM Humana
$395.51 /

+4.41 (+1.13%)

HRC Hill-Rom
$98.94 /

-2.17 (-2.15%)

ESTA Establishment Labs
$16.25 /

-0.86 (-5.03%)

CDXS Codexis
$11.15 /

-0.42 (-3.63%)

APLT Applied Therapeutics
$47.53 /

+2.41 (+5.34%)

ANGO AngioDynamics
$11.05 /

+0.11 (+1.01%)

AMED Amedisys
$190.01 /

-2.98 (-1.54%)

AHCO AdaptHealth
$16.68 /

+0.18 (+1.09%)

RDHL RedHill Biopharma
$7.19 /

+0.28 (+4.05%)

02/27/20 Roth Capital
RedHill Biopharma price target lowered to $15 from $20.25 at Roth Capital
07/12/19 WBB Securities
RedHill Biopharma upgraded to Strong Buy from Buy at WBB Securities
ANGO AngioDynamics
$11.05 /

+0.11 (+1.01%)

04/08/20
Fly Intel: Top five analyst downgrades
04/08/20 KeyBanc
AngioDynamics downgraded to Sector Weight from Overweight at KeyBanc
04/07/20 KeyBanc
AngioDynamics downgraded to Sector Weight from Overweight at KeyBanc
12/30/19 Stifel
Avanos makes 'welcome addition' with 'highly experienced' CFO, says Stifel
CDXS Codexis
$11.15 /

-0.42 (-3.63%)

03/10/20 Benchmark
Codexis initiated with a Buy at Benchmark
AHCO AdaptHealth
$16.68 /

+0.18 (+1.09%)

02/28/20 Deutsche Bank
AdaptHealth price target raised to $19 from $12 at Deutsche Bank
01/31/20
Fly Intel: Top five analyst initiations
01/30/20 Stifel
AdaptHealth initiated with a Buy at Stifel
01/07/20 Jefferies
Jefferies starts AdaptHealth at Buy with $15 price target
APLT Applied Therapeutics
$47.53 /

+2.41 (+5.34%)

04/22/20
Fly Intel: Top five analyst initiations
04/22/20 Goldman Sachs
Applied Therapeutics initiated with a Buy at Goldman Sachs
02/27/20 Barclays
Applied Therapeutics initiated with an Overweight at Barclays
02/27/20 Barclays
Applied Therapeutics initiated with an Overweight at Barclays
TFX Teleflex
$346.33 /

-6.665 (-1.89%)

05/01/20 Piper Sandler
Teleflex price target lowered to $375 from $425 at Piper Sandler
04/03/20 Raymond James
Teleflex price target lowered to $360 from $450 at Raymond James
02/20/20 Piper Sandler
Teleflex price target raised to $425 from $400 at Piper Sandler
12/12/19 Wells Fargo
SeaSpine, Glaukos double-downgraded to Underweight at Wells Fargo
UHS Universal Health
$101.01 /

+0.55 (+0.55%)

04/29/20 Deutsche Bank
Universal Health price target lowered to $135 from $165 at Deutsche Bank
04/28/20 Citi
Universal Health price target lowered to $128 from $157 at Citi
03/26/20 JPMorgan
Channel checks suggest hospital total revenues down 40%-60%, says JPMorgan
03/23/20 BofA
Universal Health downgraded to Neutral on Vegas recession risk at BofA
HRC Hill-Rom
$98.94 /

-2.17 (-2.15%)

03/17/20 Barclays
Hill-Rom upgraded to Overweight from Equal Weight at Barclays
12/17/19 Morgan Stanley
Hill-Rom upgraded to Overweight on accelerating momentum at Morgan Stanley
12/17/19 Morgan Stanley
Hill-Rom upgraded to Overweight from Equal Weight at Morgan Stanley
06/27/19 Raymond James
Hill-Rom's DoD contract win a 'nice development,' says Raymond James
NVRO Nevro
$122.31 /

+0.47 (+0.39%)

05/06/20 Citi
Nevro price target raised to $137 from $130 at Citi
04/02/20 SunTrust
Nevro price target lowered to $120 from $146 at SunTrust
04/02/20 Wells Fargo
Nevro price target lowered to $126 from $158 at Wells Fargo
03/04/20 Citi
Nevro initiated with a Buy at Citi
AMED Amedisys
$190.01 /

-2.98 (-1.54%)

05/11/20 Raymond James
Amedisys price target lowered to $210 from $225 at Raymond James
05/07/20 Benchmark
Amedisys downgraded to Hold on limited near-term visibility at Benchmark
05/07/20 Benchmark
Amedisys downgraded to Hold from Buy at Benchmark
03/09/20 Benchmark
Benchmark upgrades Amedisys to Buy on Home Health boost from crowded hospitals
ESTA Establishment Labs
$16.25 /

-0.86 (-5.03%)

05/14/20
Fly Intel: Top five analyst initiations
05/14/20 Goldman Sachs
Establishment Labs initiated with a Neutral at Goldman Sachs
01/03/20 BTIG
Zimmer Biomet, Staar Surgical, ViewRay among top 2020 picks at BTIG
07/24/19 Wells Fargo
Allergan recall to benefit Establishment and Sientra, says Wells Fargo
HUM Humana
$395.51 /

+4.41 (+1.13%)

05/04/20 Mizuho
Humana price target raised to $420 from $405 at Mizuho
04/30/20 Credit Suisse
Humana price target raised to $423 from $400 at Credit Suisse
04/30/20 Oppenheimer
Humana price target raised to $425 from $400 at Oppenheimer
04/29/20 Cantor Fitzgerald
Humana comments on telephonic sales 'positive' for eHealth, says Cantor
VKTX Viking Therapeutics
$7.05 /

-0.09 (-1.26%)

05/05/20 Chardan
Viking Therapeutics initiated with a Buy at Chardan
05/04/20 B. Riley FBR
Viking Therapeutics price target lowered to $12 from $16 at B. Riley FBR
05/01/20 BTIG
Viking Therapeutics initiated with a Buy at BTIG
02/27/20 H.C. Wainwright
Viking Therapeutics price target lowered to $18 from $31 at H.C. Wainwright
WST West Pharmaceutical
$211.46 /

-7.14 (-3.27%)

04/24/20 BofA
West Pharmaceutical upgraded to Neutral from Underperform at BofA
04/24/20 BofA
West Pharmaceutical upgraded to Neutral from Underperform at BofA
12/12/19
Fly Intel: Top five analyst downgrades
12/12/19 BofA
West Pharmaceutical downgraded to Underperform from Neutral at BofA/Merrill
WST West Pharmaceutical
$211.46 /

-7.14 (-3.27%)

VKTX Viking Therapeutics
$7.05 /

-0.09 (-1.26%)

UHS Universal Health
$101.01 /

+0.55 (+0.55%)

TFX Teleflex
$346.33 /

-6.665 (-1.89%)

RDHL RedHill Biopharma
$7.19 /

+0.28 (+4.05%)

NVRO Nevro
$122.31 /

+0.47 (+0.39%)

HUM Humana
$395.51 /

+4.41 (+1.13%)

HRC Hill-Rom
$98.94 /

-2.17 (-2.15%)

ESTA Establishment Labs
$16.25 /

-0.86 (-5.03%)

CDXS Codexis
$11.15 /

-0.42 (-3.63%)

APLT Applied Therapeutics
$47.53 /

+2.41 (+5.34%)

ANGO AngioDynamics
$11.05 /

+0.11 (+1.01%)

AMED Amedisys
$190.01 /

-2.98 (-1.54%)

AHCO AdaptHealth
$16.68 /

+0.18 (+1.09%)

UHS Universal Health
$101.01 /

+0.55 (+0.55%)

HUM Humana
$395.51 /

+4.41 (+1.13%)

VKTX Viking Therapeutics
$7.05 /

-0.09 (-1.26%)

UHS Universal Health
$101.01 /

+0.55 (+0.55%)

NVRO Nevro
$122.31 /

+0.47 (+0.39%)

HUM Humana
$395.51 /

+4.41 (+1.13%)

APLT Applied Therapeutics
$47.53 /

+2.41 (+5.34%)

ANGO AngioDynamics
$11.05 /

+0.11 (+1.01%)

VKTX Viking Therapeutics
$7.05 /

-0.09 (-1.26%)

HUM Humana
$395.51 /

+4.41 (+1.13%)

Conference/Events
UBS to hold a virtual conference » 04:55
05/19/20
05/19
04:55
05/19/20
04:55
RDHL

RedHill Biopharma

$6.91 /

+0.18 (+2.67%)

, ANGO

AngioDynamics

$10.94 /

+0.93 (+9.29%)

, CDXS

Codexis

$11.57 /

+0.47 (+4.23%)

, AHCO

AdaptHealth

$16.50 /

+0.21 (+1.29%)

, APLT

Applied Therapeutics

$45.12 /

+1.22 (+2.78%)

, TFX

Teleflex

$353.00 /

+18.395 (+5.50%)

, UHS

Universal Health

$100.46 /

+7.86 (+8.49%)

, HRC

Hill-Rom

$101.11 /

+1.3 (+1.30%)

, NVRO

Nevro

$121.84 /

+4.09 (+3.47%)

, AMED

Amedisys

$192.99 /

+8.12 (+4.39%)

, ESTA

Establishment Labs

$17.11 /

+0.71 (+4.33%)

, HUM

Humana

$391.10 /

-7.25 (-1.82%)

, VKTX

Viking Therapeutics

$7.14 /

+0.04 (+0.56%)

, WST

West Pharmaceutical

$218.60 /

+4.73 (+2.21%)

Global Healthcare Virtual…

Global Healthcare Virtual Conference will be held on May 18-20.

ShowHide Related Items >><<
WST West Pharmaceutical
$218.60 /

+4.73 (+2.21%)

VKTX Viking Therapeutics
$7.14 /

+0.04 (+0.56%)

UHS Universal Health
$100.46 /

+7.86 (+8.49%)

TFX Teleflex
$353.00 /

+18.395 (+5.50%)

RDHL RedHill Biopharma
$6.91 /

+0.18 (+2.67%)

NVRO Nevro
$121.84 /

+4.09 (+3.47%)

HUM Humana
$391.10 /

-7.25 (-1.82%)

HRC Hill-Rom
$101.11 /

+1.3 (+1.30%)

ESTA Establishment Labs
$17.11 /

+0.71 (+4.33%)

CDXS Codexis
$11.57 /

+0.47 (+4.23%)

APLT Applied Therapeutics
$45.12 /

+1.22 (+2.78%)

ANGO AngioDynamics
$10.94 /

+0.93 (+9.29%)

AMED Amedisys
$192.99 /

+8.12 (+4.39%)

AHCO AdaptHealth
$16.50 /

+0.21 (+1.29%)

RDHL RedHill Biopharma
$6.91 /

+0.18 (+2.67%)

02/27/20 Roth Capital
RedHill Biopharma price target lowered to $15 from $20.25 at Roth Capital
07/12/19 WBB Securities
RedHill Biopharma upgraded to Strong Buy from Buy at WBB Securities
ANGO AngioDynamics
$10.94 /

+0.93 (+9.29%)

04/08/20
Fly Intel: Top five analyst downgrades
04/08/20 KeyBanc
AngioDynamics downgraded to Sector Weight from Overweight at KeyBanc
04/07/20 KeyBanc
AngioDynamics downgraded to Sector Weight from Overweight at KeyBanc
12/30/19 Stifel
Avanos makes 'welcome addition' with 'highly experienced' CFO, says Stifel
CDXS Codexis
$11.57 /

+0.47 (+4.23%)

03/10/20 Benchmark
Codexis initiated with a Buy at Benchmark
AHCO AdaptHealth
$16.50 /

+0.21 (+1.29%)

02/28/20 Deutsche Bank
AdaptHealth price target raised to $19 from $12 at Deutsche Bank
01/31/20
Fly Intel: Top five analyst initiations
01/30/20 Stifel
AdaptHealth initiated with a Buy at Stifel
01/07/20 Jefferies
Jefferies starts AdaptHealth at Buy with $15 price target
APLT Applied Therapeutics
$45.12 /

+1.22 (+2.78%)

04/22/20
Fly Intel: Top five analyst initiations
04/22/20 Goldman Sachs
Applied Therapeutics initiated with a Buy at Goldman Sachs
02/27/20 Barclays
Applied Therapeutics initiated with an Overweight at Barclays
02/27/20 Barclays
Applied Therapeutics initiated with an Overweight at Barclays
TFX Teleflex
$353.00 /

+18.395 (+5.50%)

05/01/20 Piper Sandler
Teleflex price target lowered to $375 from $425 at Piper Sandler
04/03/20 Raymond James
Teleflex price target lowered to $360 from $450 at Raymond James
02/20/20 Piper Sandler
Teleflex price target raised to $425 from $400 at Piper Sandler
12/12/19 Wells Fargo
SeaSpine, Glaukos double-downgraded to Underweight at Wells Fargo
UHS Universal Health
$100.46 /

+7.86 (+8.49%)

04/29/20 Deutsche Bank
Universal Health price target lowered to $135 from $165 at Deutsche Bank
04/28/20 Citi
Universal Health price target lowered to $128 from $157 at Citi
03/26/20 JPMorgan
Channel checks suggest hospital total revenues down 40%-60%, says JPMorgan
03/23/20 BofA
Universal Health downgraded to Neutral on Vegas recession risk at BofA
HRC Hill-Rom
$101.11 /

+1.3 (+1.30%)

03/17/20 Barclays
Hill-Rom upgraded to Overweight from Equal Weight at Barclays
12/17/19 Morgan Stanley
Hill-Rom upgraded to Overweight on accelerating momentum at Morgan Stanley
12/17/19 Morgan Stanley
Hill-Rom upgraded to Overweight from Equal Weight at Morgan Stanley
06/27/19 Raymond James
Hill-Rom's DoD contract win a 'nice development,' says Raymond James
NVRO Nevro
$121.84 /

+4.09 (+3.47%)

05/06/20 Citi
Nevro price target raised to $137 from $130 at Citi
04/02/20 SunTrust
Nevro price target lowered to $120 from $146 at SunTrust
04/02/20 Wells Fargo
Nevro price target lowered to $126 from $158 at Wells Fargo
03/04/20 Citi
Nevro initiated with a Buy at Citi
AMED Amedisys
$192.99 /

+8.12 (+4.39%)

05/11/20 Raymond James
Amedisys price target lowered to $210 from $225 at Raymond James
05/07/20 Benchmark
Amedisys downgraded to Hold on limited near-term visibility at Benchmark
05/07/20 Benchmark
Amedisys downgraded to Hold from Buy at Benchmark
03/09/20 Benchmark
Benchmark upgrades Amedisys to Buy on Home Health boost from crowded hospitals
ESTA Establishment Labs
$17.11 /

+0.71 (+4.33%)

05/14/20
Fly Intel: Top five analyst initiations
05/14/20 Goldman Sachs
Establishment Labs initiated with a Neutral at Goldman Sachs
01/03/20 BTIG
Zimmer Biomet, Staar Surgical, ViewRay among top 2020 picks at BTIG
07/24/19 Wells Fargo
Allergan recall to benefit Establishment and Sientra, says Wells Fargo
HUM Humana
$391.10 /

-7.25 (-1.82%)

05/04/20 Mizuho
Humana price target raised to $420 from $405 at Mizuho
04/30/20 Credit Suisse
Humana price target raised to $423 from $400 at Credit Suisse
04/30/20 Oppenheimer
Humana price target raised to $425 from $400 at Oppenheimer
04/29/20 Cantor Fitzgerald
Humana comments on telephonic sales 'positive' for eHealth, says Cantor
VKTX Viking Therapeutics
$7.14 /

+0.04 (+0.56%)

05/05/20 Chardan
Viking Therapeutics initiated with a Buy at Chardan
05/04/20 B. Riley FBR
Viking Therapeutics price target lowered to $12 from $16 at B. Riley FBR
05/01/20 BTIG
Viking Therapeutics initiated with a Buy at BTIG
02/27/20 H.C. Wainwright
Viking Therapeutics price target lowered to $18 from $31 at H.C. Wainwright
WST West Pharmaceutical
$218.60 /

+4.73 (+2.21%)

04/24/20 BofA
West Pharmaceutical upgraded to Neutral from Underperform at BofA
04/24/20 BofA
West Pharmaceutical upgraded to Neutral from Underperform at BofA
12/12/19
Fly Intel: Top five analyst downgrades
12/12/19 BofA
West Pharmaceutical downgraded to Underperform from Neutral at BofA/Merrill
WST West Pharmaceutical
$218.60 /

+4.73 (+2.21%)

VKTX Viking Therapeutics
$7.14 /

+0.04 (+0.56%)

UHS Universal Health
$100.46 /

+7.86 (+8.49%)

TFX Teleflex
$353.00 /

+18.395 (+5.50%)

RDHL RedHill Biopharma
$6.91 /

+0.18 (+2.67%)

NVRO Nevro
$121.84 /

+4.09 (+3.47%)

HUM Humana
$391.10 /

-7.25 (-1.82%)

HRC Hill-Rom
$101.11 /

+1.3 (+1.30%)

ESTA Establishment Labs
$17.11 /

+0.71 (+4.33%)

CDXS Codexis
$11.57 /

+0.47 (+4.23%)

APLT Applied Therapeutics
$45.12 /

+1.22 (+2.78%)

ANGO AngioDynamics
$10.94 /

+0.93 (+9.29%)

AMED Amedisys
$192.99 /

+8.12 (+4.39%)

AHCO AdaptHealth
$16.50 /

+0.21 (+1.29%)

UHS Universal Health
$100.46 /

+7.86 (+8.49%)

HUM Humana
$391.10 /

-7.25 (-1.82%)

VKTX Viking Therapeutics
$7.14 /

+0.04 (+0.56%)

UHS Universal Health
$100.46 /

+7.86 (+8.49%)

NVRO Nevro
$121.84 /

+4.09 (+3.47%)

HUM Humana
$391.10 /

-7.25 (-1.82%)

APLT Applied Therapeutics
$45.12 /

+1.22 (+2.78%)

ANGO AngioDynamics
$10.94 /

+0.93 (+9.29%)

VKTX Viking Therapeutics
$7.14 /

+0.04 (+0.56%)

HUM Humana
$391.10 /

-7.25 (-1.82%)

Conference/Events
UBS to hold a virtual conference » 08:53
05/18/20
05/18
08:53
05/18/20
08:53
RDHL

RedHill Biopharma

$6.73 /

-0.11 (-1.61%)

, ANGO

AngioDynamics

$10.01 /

+0.01 (+0.10%)

, CDXS

Codexis

$11.10 /

+0.35 (+3.26%)

, AHCO

AdaptHealth

$16.29 /

-0.11 (-0.67%)

, APLT

Applied Therapeutics

$43.90 /

+0.85 (+1.97%)

, TFX

Teleflex

$334.60 /

+1.41 (+0.42%)

, UHS

Universal Health

$92.60 /

+1.13 (+1.24%)

, HRC

Hill-Rom

$99.81 /

+0.4 (+0.40%)

, NVRO

Nevro

$117.75 /

-2.27 (-1.89%)

, AMED

Amedisys

$184.87 /

+7.66 (+4.32%)

, ESTA

Establishment Labs

$16.40 /

-0.91 (-5.26%)

, HUM

Humana

$398.35 /

+12.43 (+3.22%)

, VKTX

Viking Therapeutics

$7.10 /

+0.2 (+2.90%)

, WST

West Pharmaceutical

$213.87 /

+3.45 (+1.64%)

Global Healthcare Virtual…

Global Healthcare Virtual Conference will be held on May 18-20.

ShowHide Related Items >><<
WST West Pharmaceutical
$213.87 /

+3.45 (+1.64%)

VKTX Viking Therapeutics
$7.10 /

+0.2 (+2.90%)

UHS Universal Health
$92.60 /

+1.13 (+1.24%)

TFX Teleflex
$334.60 /

+1.41 (+0.42%)

RDHL RedHill Biopharma
$6.73 /

-0.11 (-1.61%)

NVRO Nevro
$117.75 /

-2.27 (-1.89%)

HUM Humana
$398.35 /

+12.43 (+3.22%)

HRC Hill-Rom
$99.81 /

+0.4 (+0.40%)

ESTA Establishment Labs
$16.40 /

-0.91 (-5.26%)

CDXS Codexis
$11.10 /

+0.35 (+3.26%)

APLT Applied Therapeutics
$43.90 /

+0.85 (+1.97%)

ANGO AngioDynamics
$10.01 /

+0.01 (+0.10%)

AMED Amedisys
$184.87 /

+7.66 (+4.32%)

AHCO AdaptHealth
$16.29 /

-0.11 (-0.67%)

RDHL RedHill Biopharma
$6.73 /

-0.11 (-1.61%)

02/27/20 Roth Capital
RedHill Biopharma price target lowered to $15 from $20.25 at Roth Capital
07/12/19 WBB Securities
RedHill Biopharma upgraded to Strong Buy from Buy at WBB Securities
ANGO AngioDynamics
$10.01 /

+0.01 (+0.10%)

04/08/20
Fly Intel: Top five analyst downgrades
04/08/20 KeyBanc
AngioDynamics downgraded to Sector Weight from Overweight at KeyBanc
04/07/20 KeyBanc
AngioDynamics downgraded to Sector Weight from Overweight at KeyBanc
12/30/19 Stifel
Avanos makes 'welcome addition' with 'highly experienced' CFO, says Stifel
CDXS Codexis
$11.10 /

+0.35 (+3.26%)

03/10/20 Benchmark
Codexis initiated with a Buy at Benchmark
AHCO AdaptHealth
$16.29 /

-0.11 (-0.67%)

02/28/20 Deutsche Bank
AdaptHealth price target raised to $19 from $12 at Deutsche Bank
01/31/20
Fly Intel: Top five analyst initiations
01/30/20 Stifel
AdaptHealth initiated with a Buy at Stifel
01/07/20 Jefferies
Jefferies starts AdaptHealth at Buy with $15 price target
APLT Applied Therapeutics
$43.90 /

+0.85 (+1.97%)

04/22/20
Fly Intel: Top five analyst initiations
04/22/20 Goldman Sachs
Applied Therapeutics initiated with a Buy at Goldman Sachs
02/27/20 Barclays
Applied Therapeutics initiated with an Overweight at Barclays
02/27/20 Barclays
Applied Therapeutics initiated with an Overweight at Barclays
TFX Teleflex
$334.60 /

+1.41 (+0.42%)

05/01/20 Piper Sandler
Teleflex price target lowered to $375 from $425 at Piper Sandler
04/03/20 Raymond James
Teleflex price target lowered to $360 from $450 at Raymond James
02/20/20 Piper Sandler
Teleflex price target raised to $425 from $400 at Piper Sandler
12/12/19 Wells Fargo
SeaSpine, Glaukos double-downgraded to Underweight at Wells Fargo
UHS Universal Health
$92.60 /

+1.13 (+1.24%)

04/29/20 Deutsche Bank
Universal Health price target lowered to $135 from $165 at Deutsche Bank
04/28/20 Citi
Universal Health price target lowered to $128 from $157 at Citi
03/26/20 JPMorgan
Channel checks suggest hospital total revenues down 40%-60%, says JPMorgan
03/23/20 BofA
Universal Health downgraded to Neutral on Vegas recession risk at BofA
HRC Hill-Rom
$99.81 /

+0.4 (+0.40%)

03/17/20 Barclays
Hill-Rom upgraded to Overweight from Equal Weight at Barclays
12/17/19 Morgan Stanley
Hill-Rom upgraded to Overweight on accelerating momentum at Morgan Stanley
12/17/19 Morgan Stanley
Hill-Rom upgraded to Overweight from Equal Weight at Morgan Stanley
06/27/19 Raymond James
Hill-Rom's DoD contract win a 'nice development,' says Raymond James
NVRO Nevro
$117.75 /

-2.27 (-1.89%)

05/06/20 Citi
Nevro price target raised to $137 from $130 at Citi
04/02/20 SunTrust
Nevro price target lowered to $120 from $146 at SunTrust
04/02/20 Wells Fargo
Nevro price target lowered to $126 from $158 at Wells Fargo
03/04/20 Citi
Nevro initiated with a Buy at Citi
AMED Amedisys
$184.87 /

+7.66 (+4.32%)

05/11/20 Raymond James
Amedisys price target lowered to $210 from $225 at Raymond James
05/07/20 Benchmark
Amedisys downgraded to Hold on limited near-term visibility at Benchmark
05/07/20 Benchmark
Amedisys downgraded to Hold from Buy at Benchmark
03/09/20 Benchmark
Benchmark upgrades Amedisys to Buy on Home Health boost from crowded hospitals
ESTA Establishment Labs
$16.40 /

-0.91 (-5.26%)

05/14/20
Fly Intel: Top five analyst initiations
05/14/20 Goldman Sachs
Establishment Labs initiated with a Neutral at Goldman Sachs
01/03/20 BTIG
Zimmer Biomet, Staar Surgical, ViewRay among top 2020 picks at BTIG
07/24/19 Wells Fargo
Allergan recall to benefit Establishment and Sientra, says Wells Fargo
HUM Humana
$398.35 /

+12.43 (+3.22%)

05/04/20 Mizuho
Humana price target raised to $420 from $405 at Mizuho
04/30/20 Credit Suisse
Humana price target raised to $423 from $400 at Credit Suisse
04/30/20 Oppenheimer
Humana price target raised to $425 from $400 at Oppenheimer
04/29/20 Cantor Fitzgerald
Humana comments on telephonic sales 'positive' for eHealth, says Cantor
VKTX Viking Therapeutics
$7.10 /

+0.2 (+2.90%)

05/05/20 Chardan
Viking Therapeutics initiated with a Buy at Chardan
05/04/20 B. Riley FBR
Viking Therapeutics price target lowered to $12 from $16 at B. Riley FBR
05/01/20 BTIG
Viking Therapeutics initiated with a Buy at BTIG
02/27/20 H.C. Wainwright
Viking Therapeutics price target lowered to $18 from $31 at H.C. Wainwright
WST West Pharmaceutical
$213.87 /

+3.45 (+1.64%)

04/24/20 BofA
West Pharmaceutical upgraded to Neutral from Underperform at BofA
04/24/20 BofA
West Pharmaceutical upgraded to Neutral from Underperform at BofA
12/12/19
Fly Intel: Top five analyst downgrades
12/12/19 BofA
West Pharmaceutical downgraded to Underperform from Neutral at BofA/Merrill
WST West Pharmaceutical
$213.87 /

+3.45 (+1.64%)

VKTX Viking Therapeutics
$7.10 /

+0.2 (+2.90%)

UHS Universal Health
$92.60 /

+1.13 (+1.24%)

TFX Teleflex
$334.60 /

+1.41 (+0.42%)

RDHL RedHill Biopharma
$6.73 /

-0.11 (-1.61%)

NVRO Nevro
$117.75 /

-2.27 (-1.89%)

HUM Humana
$398.35 /

+12.43 (+3.22%)

HRC Hill-Rom
$99.81 /

+0.4 (+0.40%)

ESTA Establishment Labs
$16.40 /

-0.91 (-5.26%)

CDXS Codexis
$11.10 /

+0.35 (+3.26%)

APLT Applied Therapeutics
$43.90 /

+0.85 (+1.97%)

ANGO AngioDynamics
$10.01 /

+0.01 (+0.10%)

AMED Amedisys
$184.87 /

+7.66 (+4.32%)

AHCO AdaptHealth
$16.29 /

-0.11 (-0.67%)

UHS Universal Health
$92.60 /

+1.13 (+1.24%)

HUM Humana
$398.35 /

+12.43 (+3.22%)

VKTX Viking Therapeutics
$7.10 /

+0.2 (+2.90%)

UHS Universal Health
$92.60 /

+1.13 (+1.24%)

NVRO Nevro
$117.75 /

-2.27 (-1.89%)

HUM Humana
$398.35 /

+12.43 (+3.22%)

APLT Applied Therapeutics
$43.90 /

+0.85 (+1.97%)

ANGO AngioDynamics
$10.01 /

+0.01 (+0.10%)

AMED Amedisys
$184.87 /

+7.66 (+4.32%)

VKTX Viking Therapeutics
$7.10 /

+0.2 (+2.90%)

HUM Humana
$398.35 /

+12.43 (+3.22%)

Over a month ago
Downgrade
Fly Intel: Top five analyst downgrades » 10:48
04/08/20
04/08
10:48
04/08/20
10:48
DIS

Disney

$99.81 /

-1.29 (-1.28%)

, W

Wayfair

$77.09 /

-0.345 (-0.45%)

, AMC

AMC Entertainment

$2.91 /

-0.21 (-6.73%)

, AZO

AutoZone

$923.00 /

+12.44 (+1.37%)

, ANGO

AngioDynamics

$9.56 /

-0.87 (-8.34%)

Catch up on today's…

Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Disney (DIS) downgraded to Equal Weight from Overweight at Wells Fargo with analyst Steven Cahall saying he still believes Disney+ can offset a declining environment for Media Networks, but is concerned by this "unique and severe downturn for Parks." 2. Wayfair (W) downgraded to Underweight from Neutral at JPMorgan with analyst Christopher Horvers saying he recommends selling the shares following the recent rally. 3. AMC Entertainment (AMC) downgraded to Sell from Hold at Loop Capital with analyst Alan Gould saying the company was already over-levered going into the COVID-19 storm and he had previously expressed concerns about its liquidity. 4. AutoZone (AZO) downgraded to Neutral from Buy at BofA with analyst Elizabeth Suzuki citing "mounting risks" to the medium-term auto parts replacement demand and the stock's "less attractive valuation" relative to its peers. 5. AngioDynamics (ANGO) downgraded to Sector Weight from Overweight at KeyBanc with analyst Matthew Mishan saying acquisitions has not been the expected growth driver he expected and that he now sees a slower rollout for Auryon. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.

ShowHide Related Items >><<
DIS Disney
$99.81 /

-1.29 (-1.28%)

04/08/20 Piper Sandler
Netflix retakes lead in teen video share, Piper Sandler survey shows
04/07/20
Wells Fargo downgrades Disney due to 'severe' downturn for Parks
04/07/20 Wells Fargo
Disney downgraded to Equal Weight from Overweight at Wells Fargo
04/03/20 Loop Capital
Disney price target lowered to $125 from $150 at Loop Capital
W Wayfair
$77.09 /

-0.345 (-0.45%)

04/08/20 JPMorgan
JPMorgan downgrades Wayfair to Underweight, calls revenue surge unsustainable
04/08/20 JPMorgan
Wayfair downgraded to Underweight from Neutral at JPMorgan
04/07/20 BofA
Wayfair upgraded to Buy from Neutral at BofA
04/07/20 BofA
Wayfair upgraded to Buy from Neutral at BofA
AMC AMC Entertainment
$2.91 /

-0.21 (-6.73%)

04/08/20 RBC Capital
EPR Properties has highest concentration of AMC leases, says RBC Capital
04/08/20 Loop Capital
AMC Entertainment downgraded to Sell from Hold at Loop Capital
04/08/20 Loop Capital
AMC Entertainment downgraded to Sell from Hold at Loop Capital
03/26/20 RBC Capital
Cheesecake, AMC news highlight tenants financial stress, says RBC Capital
AZO AutoZone
$923.00 /

+12.44 (+1.37%)

04/08/20 BofA
AutoZone downgraded to Neutral from Buy at BofA
04/08/20 BofA
AutoZone downgraded to Neutral from Buy at BofA
03/30/20 Credit Suisse
AutoZone price target lowered to $1,015 from $1,350 at Credit Suisse
03/25/20 Wolfe Research
AutoZone upgraded to Outperform from Peer Perform at Wolfe Research
ANGO AngioDynamics
$9.56 /

-0.87 (-8.34%)

04/08/20 KeyBanc
AngioDynamics downgraded to Sector Weight from Overweight at KeyBanc
04/07/20 KeyBanc
AngioDynamics downgraded to Sector Weight from Overweight at KeyBanc
12/30/19 Stifel
Avanos makes 'welcome addition' with 'highly experienced' CFO, says Stifel
10/04/19 KeyBanc
AngioDynamics price target lowered to $21 from $30 at KeyBanc
Downgrade
AngioDynamics downgraded to Sector Weight from Overweight at KeyBanc » 05:40
04/08/20
04/08
05:40
04/08/20
05:40
ANGO

AngioDynamics

$10.43 /

+0.24 (+2.36%)

KeyBanc analyst Matthew…

KeyBanc analyst Matthew Mishan downgraded AngioDynamics to Sector Weight from Overweight without a price target. The analyst says acquisitions has not been the expected growth driver he expected and that he now sees a slower rollout for Auryon. AngioDynamics' portfolio transformation was the right strategic move, but it now has a "less visible floor" for earnings and a balance sheet that is "not a clear area of strength," Mishan tells investors in a research note.

ShowHide Related Items >><<
ANGO AngioDynamics
$10.43 /

+0.24 (+2.36%)

04/07/20 KeyBanc
AngioDynamics downgraded to Sector Weight from Overweight at KeyBanc
12/30/19 Stifel
Avanos makes 'welcome addition' with 'highly experienced' CFO, says Stifel
10/04/19 KeyBanc
AngioDynamics price target lowered to $21 from $30 at KeyBanc
Downgrade
AngioDynamics downgraded to Sector Weight from Overweight at KeyBanc » 20:01
04/07/20
04/07
20:01
04/07/20
20:01
ANGO

AngioDynamics

$10.43 /

+0.24 (+2.36%)

KeyBanc analyst Matthew…

KeyBanc analyst Matthew Mishan downgraded AngioDynamics to Sector Weight from Overweight.

ShowHide Related Items >><<
ANGO AngioDynamics
$10.43 /

+0.24 (+2.36%)

12/30/19 Stifel
Avanos makes 'welcome addition' with 'highly experienced' CFO, says Stifel
10/04/19 KeyBanc
AngioDynamics price target lowered to $21 from $30 at KeyBanc
On The Fly
Fly Intel: Pre-market Movers » 09:03
04/07/20
04/07
09:03
04/07/20
09:03
XOM

Exxon Mobil

$40.45 /

+1.25 (+3.19%)

, M

Macy's

$5.65 /

+0.84 (+17.48%)

, W

Wayfair

$71.53 /

+20.86 (+41.17%)

, HOLX

Hologic

$35.82 /

+3.01 (+9.17%)

, NGM

NGM Biopharmaceuticals

$13.39 /

+1.07 (+8.69%)

, GBX

Greenbrier

$14.30 /

+1.255 (+9.62%)

, ANGO

AngioDynamics

$10.19 /

+0.55 (+5.71%)

, LNN

Lindsay

$93.92 /

+10.01 (+11.93%)

, SEAC

SeaChange

$3.61 /

+0.34 (+10.40%)

Check out this morning's…

Open Full Text

ShowHide Related Items >><<
XOM Exxon Mobil
$40.45 /

+1.25 (+3.19%)

04/02/20
Fly Intel: Top five analyst downgrades
04/02/20 Argus
Exxon Mobil downgraded to Hold from Buy at Argus
04/02/20 Argus
Exxon Mobil downgraded to Hold from Buy at Argus
03/20/20 Wells Fargo
Exxon Mobil price target lowered to $44 from $63 at Wells Fargo
M Macy's
$5.65 /

+0.84 (+17.48%)

03/27/20 Cleveland Research
Macy's downgraded to Underperform at Cleveland Research
03/27/20 Cleveland Research
Macy's downgraded to Underperform from Neutral at Cleveland Research
03/19/20 Morgan Stanley
Morgan Stanley lowers targets for Gap, Macy's, and four other levered retailers
02/06/20 Cowen
Cowen encouraged by Macy's comeback plan, remains "show-me" story
W Wayfair
$71.53 /

+20.86 (+41.17%)

04/07/20 BofA
Wayfair upgraded to Buy from Neutral at BofA
04/07/20 BofA
Wayfair upgraded to Buy from Neutral at BofA
04/06/20 Stifel
Wayfair price target raised to $75 from $70 at Stifel
04/06/20 Baird
Baird boosts Wayfair target to $73 after positive preannouncement
HOLX Hologic
$35.82 /

+3.01 (+9.17%)

04/07/20 Wells Fargo
Hologic upgraded to Overweight at Wells Fargo
04/07/20 Wells Fargo
Hologic upgraded to Overweight from Equal Weight at Wells Fargo
04/02/20 Needham
Hologic price target lowered to $52 from $62 at Needham
03/27/20 Morgan Stanley
Hologic upgraded to Equal Weight from Underweight at Morgan Stanley
NGM NGM Biopharmaceuticals
$13.39 /

+1.07 (+8.69%)

04/06/20 Raymond James
NGM Biopharmaceuticals initiated with a Strong Buy at Raymond James
03/31/20 H.C. Wainwright
Akero's BALANCED study results 'quite impressive,' says H.C. Wainwright
03/27/20 Citi
NGM Biopharmaceuticals price target lowered to $28 from $34 at Citi
02/26/20 B. Riley FBR
NGM Biopharmaceuticals price target raised to $30 from $24 at B. Riley FBR
GBX Greenbrier
$14.30 /

+1.255 (+9.62%)

01/14/20 Wells Fargo
Greenbrier downgraded to Underweight from Equal Weight at Wells Fargo
11/08/19 Susquehanna
Greenbrier downgraded to Neutral from Positive at Susquehanna
09/16/19
Greenbrier upgraded to Overweight at KeyBanc
09/16/19 KeyBanc
Greenbrier upgraded to Overweight from Sector Weight at KeyBanc
ANGO AngioDynamics
$10.19 /

+0.55 (+5.71%)

12/30/19 Stifel
Avanos makes 'welcome addition' with 'highly experienced' CFO, says Stifel
10/04/19 KeyBanc
AngioDynamics price target lowered to $21 from $30 at KeyBanc
LNN Lindsay
$93.92 /

+10.01 (+11.93%)

03/17/20 Sidoti
Lindsay upgraded to Buy from Neutral at Sidoti
05/15/19
Lindsay downgraded to Neutral at Boenning & Scattergood
05/15/19 Boenning & Scattergood
Lindsay downgraded to Neutral from Outperform at Boenning & Scattergood
SEAC SeaChange
$3.61 /

+0.34 (+10.40%)

12/05/19 Lake Street
Lake Street upgrades SeaChange to Buy, boosts target to $4.50
12/05/19 Lake Street
SeaChange upgraded to Buy from Hold at Lake Street
Earnings
AngioDynamics withdraws FY20 guidance due to COVID-19 » 07:13
04/07/20
04/07
07:13
04/07/20
07:13
ANGO

AngioDynamics

$10.19 /

+0.55 (+5.71%)

As a result of the…

As a result of the ongoing pandemic, health systems throughout the country, many of which are AngioDynamics customers, are currently prioritizing the care of COVID-19 patients. Consequently, certain of the procedures that the company supports have been, and will continue to be, impacted. Given the uncertainty surrounding the magnitude and duration of these impacts, management is withdrawing its FY20 financial guidance.

ShowHide Related Items >><<
ANGO AngioDynamics
$10.19 /

+0.55 (+5.71%)

12/30/19 Stifel
Avanos makes 'welcome addition' with 'highly experienced' CFO, says Stifel
10/04/19 KeyBanc
AngioDynamics price target lowered to $21 from $30 at KeyBanc
Earnings
AngioDynamics reports Q3 adj. EPS 1c, consensus (3c) » 07:12
04/07/20
04/07
07:12
04/07/20
07:12
ANGO

AngioDynamics

$10.19 /

+0.55 (+5.71%)

Reports Q3 revenue…

Reports Q3 revenue $69.8M, consensus $68.55M. "The health and safety of the team is our top priority, and I want to thank each of our team members for the resiliency they have shown. We are very pleased with our third quarter results, as increases across all three of our businesses drove solid ex-Asclera top-line growth of 9.3%," commented Jim Clemmer, President and CEO of AngioDynamics. "Looking ahead, we are operating in a very dynamic macro environment, and the coming months are likely to present further challenges. However, our healthy balance sheet and world-class team leave us well-prepared to weather those challenges. We experienced strong momentum during the third quarter, and we look forward to building on that momentum once the environment begins to normalize, as we believe that the long-term fundamentals and growth drivers of our business remain intact. All of us at AngioDynamics remain steadfastly focused on the health and safety of our employees and patients and ensuring that our physicians and customers have uninterrupted access to our innovative product portfolio in order to deliver the highest quality care possible."

ShowHide Related Items >><<
ANGO AngioDynamics
$10.19 /

+0.55 (+5.71%)

12/30/19 Stifel
Avanos makes 'welcome addition' with 'highly experienced' CFO, says Stifel
10/04/19 KeyBanc
AngioDynamics price target lowered to $21 from $30 at KeyBanc
Over a quarter ago
Hot Stocks
AngioDynamics appoints Stephen Trowbridge as CFO » 08:12
02/06/20
02/06
08:12
02/06/20
08:12
ANGO

AngioDynamics

$13.74 /

-0.05 (-0.36%)

AngioDynamics announced…

AngioDynamics announced that it has appointed Stephen Trowbridge to the role of Executive Vice President and CFO, effective February 5. Trowbridge has served as the company's Interim CFO since October 22, 2019.

ShowHide Related Items >><<
ANGO AngioDynamics
$13.74 /

-0.05 (-0.36%)

12/30/19 Stifel
Avanos makes 'welcome addition' with 'highly experienced' CFO, says Stifel
10/04/19 KeyBanc
AngioDynamics price target lowered to $21 from $30 at KeyBanc
04/01/19 KeyBanc
AngioDynamics upgraded to Overweight from Sector Weight at KeyBanc

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.